Gilbert S. Omenn

Gilbert Omenn is the Harold T. Shapiro Distinguished University Professor of Computational Medicine & Bioinformatics, Internal Medicine, Human Genetics and Public Health and founding director of the Center for Computational Medicine & Bioinformatics at the University of Michigan, Ann Arbor. His research is focused on proteo-genomics and bioinformatics of cancers. He led the global Human Proteome Project (www.hupo.org) for the past decade. He previously worked on biochemical genetics of the brain, cancer prevention, health promotion and disease prevention for older adults, and science and health policy. He is an author of 620 publications with 39,000 citations/h-index 81 and editor/author of 18 books.

He was a Research Associate with Christian B. Anfinsen at the National Institute of Arthritic and Metabolic Diseases; a Howard Hughes Medical Institute Investigator at the University of Washington (UW); and a member of the National Cancer Advisory Board; the National Heart, Lung and Blood Institute Council, the Society of Fellows of the National Center for Minority Health & Health Disparities and the Scientific Management Review Committee for the National Institutes of Health. He was Dean of the School of Public Health & Community Medicine at the UW and Executive Vice-President for Medical Affairs and CEO of the Health System at the University of Michigan. He served as a White House Fellow at the U.S. Atomic Energy Commission, Associate Director of the White House Office of Science & Technology Policy and the Office of Management & Budget, and President of the American Association for the Advancement of Science. He chaired the Presidential/Congressional Commission on Risk Assessment & Risk Management in the 1990s. He served on the boards of Amgen, Inc. and Rohm & Haas Company. He currently serves on boards of the Hastings Center for Bioethics, the Center for Public Integrity, the Weizmann Institute of Science and biotech firms.